MedTrace Logo

A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells

NCT04405297 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2025-10-22

No results posted yet for this study

Summary

This is a prospective, multi-location safety and effectiveness study, and data registry of autologous adult ADRCs generated by the Transpose® RT System in subjects with OA in the shoulder, wrist, knee, hip, or ankle.

Conditions

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Ankle Osteoarthritis
  • Shoulder Osteoarthritis
  • Wrist Osteoarthritis

Interventions

DEVICE

Adipose-derived regenerative cells

Adipose-derived regenerative cells will be obtained from a small-volume lipoaspirate procedure. The lipoaspirate will then be enzymatically digested to produce a stromal vascular fraction (SVF) that will be injected into the targeted joint.

Sponsors & Collaborators

  • Sanford Health

    lead OTHER

Principal Investigators

  • David A. Pearce, PhD · Sanford Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-24
Primary Completion
2024-09-23
Completion
2024-09-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405297 on ClinicalTrials.gov